Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2630 |
|
Actual shortage: | 254 (10%) | |
Anticipated shortage: | 2 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2365 (90%) | |
Discontinuation Reports |
249 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 246 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
318 (11%) |
|
Overdue reports |
22 (8%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NAPROXEN EC | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2023-04-27 | 2023-06-09 | 190740 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-11-03 | 195109 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195112 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195207 |
NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2023-06-19 | 2023-08-18 | 195545 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-06-19 | 2023-06-27 | 195554 |
ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195585 |
ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-06-19 | 2023-08-17 | 195629 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-20 | 2023-11-03 | 195754 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195870 |
TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-06 | 195894 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-07-06 | 2023-07-28 | 197743 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Actual shortage | 2023-08-03 | 2024-03-14 | 200864 |
TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Actual shortage | 2023-10-12 | 2024-02-07 | 206901 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-10-19 | 2024-02-15 | 207500 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Actual shortage | 2023-10-19 | 2024-03-18 | 207503 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-10-19 | 2023-12-07 | 207539 |
TEVA-CEPHALEXIN | 250MG | TABLET | Actual shortage | 2023-11-03 | 2024-03-14 | 209136 |
TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211970 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Actual shortage | 2024-02-29 | 2024-03-21 | 220977 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |